APA (7th ed.) Citation

Alsaadi, T., Suliman, R., Khandoker, A. H., Aljaafari, M. N., Alsabbagh, G., Saidam, M., & Hamoulila, K. (2026). Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE. Neurology & Therapy, 15(4), 1763. https://doi.org/10.1007/s40120-026-00961-9

Chicago Style (17th ed.) Citation

Alsaadi, Taoufik, Reem Suliman, Ahsan H. Khandoker, Mariam Nasser Aljaafari, Ghaith Alsabbagh, Mohammad Saidam, and Khaled Hamoulila. "Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE." Neurology & Therapy 15, no. 4 (2026): 1763. https://doi.org/10.1007/s40120-026-00961-9.

MLA (9th ed.) Citation

Alsaadi, Taoufik, et al. "Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE." Neurology & Therapy, vol. 15, no. 4, 2026, p. 1763, https://doi.org/10.1007/s40120-026-00961-9.